BUZZ-DaVita falls on report of FTC launching an investigation into co ** Shares of dialysis firm DaVita DVA.N fall 2.8% to $137.59 ** The U.S. Federal Trade Commission is investigating DVA and Fresenius Medical Carev FMEG.DE over allegations that the companies have been illegally thwarting smaller competitors, Politico reported on Saturday ** The F

UPDATE 1-US FTC probing DaVita, Fresenius Medical, Politico reports Adds more details in paragraph 4, background in paragraph 6 July 13 (Reuters) - The U.S. Federal Trade Commission (FTC) is investigating healthcare providers DaVita DVA.N and Fresenius Medical Care FMEG.DE over allegations that the companies have been illegally thwarting smaller competitors, Politico reported on Saturday, citing three people familiar with the matter.

BRIEF-US Federal Trade Commission Is Investigating Dialysis Providers Davita And Fresenius Medical Care- Politico July 13 (Reuters) - US FEDERAL TRADE COMMISSION IS INVESTIGATING DIALYSIS PROVIDERS DAVITA AND FRESENIUS MEDICAL CARE- POLITICO Source https://tinyurl.com/ym3t3yby

US FTC probing DaVita, Fresenius Medical, Politico reports July 13 (Reuters) - The U.S. Federal Trade Commission (FTC) is investigating healthcare providers DaVita DVA.N and Fresenius Medical Care FMEG.DE over allegations that the companies have been illegally thwarting smaller competitors, Politico reported on Saturday, citing three people familiar with the matter.

FOCUS-AbbVie's tight grip on Humira market raises concerns about biosimilars By Patrick Wingrove June 7 (Reuters) - AbbVie’s ABBV.N top-selling arthritis drug Humira has held onto more than 80% of patients after facing nine lower-priced rivals in the U.S. in the last year, raising questions about whether the market for prescription biosimilars can survive in its current form, drug pricing experts and analysts say.

Fresenius lifts 2024 targets for private healthcare unit Helios June 5 (Reuters) - German healthcare group Fresenius FREG.DE raised the yearly guidance for its private healthcare provider Helios on Wednesday, following a strong start to 2024 and the conclusion of group-wide restructuring. The Hessian-based group expects Helios to grow its revenue by a mid-single-digit percentage and report an earnings before interests and taxes (EBIT) margin of 10% to 11% this year.

BUZZ-Top of the Street: Fresenius, Freenet, European tyremakers A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** UBS upgrades mobile retailer and service provider Freenet FNTGn.DE to "buy" from "hold", saying it benefits from competitive tensions in the German mobile market that have pushed operators to give it longer term deals ** HSBC raises German healthcare group Fresenius FREG.DE to "buy" from "hold" and increases its TP by 23% to 38 euros INITIATION

BRIEF-OEBAG Sells 13% Stake In Vamed To Fresenius June 4 (Reuters) - OEBAG says: SELLS 13% STAKE IN VAMED TO FRESENIUS PARTIES HAVE AGREED NOT TO DISCLOSE THE PURCHASE PRICE Further company coverage: FMEG.DE (Gdansk Newsroom)

EUROPE RESEARCH ROUNDUP-Allianz, Carnival, Future June 4 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Allianz, Carnival and Future, on Tuesday. HIGHLIGHTS * Allianz SE ALVG.DE : Citigroup cuts to neutral from buy * Carnival CCL.L : Peel Hunt raises to buy from add * Future Plc FUTR.L : Berenberg raises to buy from hold * Liontrust Asset Management Plc LIO.L : Deutsche Bank cuts to sell from hold * Nibe NIBEB.ST : Barclays cuts t

BRIEF-Observe Medical Subsidiary Extends Agreement With Fresenius Medical Care May 31 (Reuters) - Observe Medical ASA OBSRV.OL : OBSERVE MEDICAL ANNOUNCES THAT ITS SUBSIDIARY BIIM HAS EXTENDED ITS AGREEMENT WITH FRESENIUS MEDICAL CARE FOR SUPPLY OF WIRELESS POCKETABLE ULTRASOUND DEVICES THIS RENEWAL EXTENDS PARTNERSHIP FOR AN ADDITIONAL TWO YEARS,

BUZZ-FMC jumps after Novo Nordisk says Ozempic slows down kidney disease in trial ** Shares in German dialysis provider Fresenius Medical Care (FMC) FMEG.DE jump more than 7% after trial results showed Novo Nordisk's NOVOb.CO Ozempic slowed kidney disease progression in patients with type 2 diabetes ** Ozempic is a diabetes drug that has the same a

EUROPE RESEARCH ROUNDUP- FLSmidth, Neste, Sonova Holding May 20 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including FLSmidth, Neste and Sonova Holding, on Monday. HIGHLIGHTS * FLSmidth FLS.CO : JP Morgan raises target price to DKK 400 from DKK 310 * IMCD NV IMCD.AS : JP Morgan cuts target price to EUR 185 from EUR 188 * Neste Oyj NESTE.HE : Stifel cuts target price to EUR 37 from EUR 40 * Sonova Holding AG SOON.S : Morgan Stanley cuts

Investors demand clarity from Fresenius over dialysis group FMC FRANKFURT, May 17 (Reuters) - Investors demanded more clarity from German healthcare group Fresenius SE FREG.DE on Friday regarding its plans to cede strategic control over dialysis group Fresenius Medical Care FMEG.DE . "The volatility at Fresenius Medical Care seems to repeatedly overshadow the recent positive operating developments at Fresenius and is also deterring many potential shareholders from investing in Fresenius," said H

EUROPE RESEARCH ROUNDUP- Coloplast, National Grid, Smurfit Kappa May 13 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Coloplast, National Grid and Smurfit Kappa, on Monday. HIGHLIGHTS * AFC Ajax NV AJAX.AS : Berenberg cuts to hold from buy; cuts PT to EUR 11 from EUR 17 * Coloplast COLOB.CO : HSBC raises target price to DKK 710 from DKK 700 * JD Wetherspoon JDW.L : HSBC raises target price to 1030p from 1020p * National Grid NG.L

Fresenius Medical sees up to 2% US dialysis growth by year-end FRANKFURT, May 11 (Reuters) - The number of kidney dialysis sessions provided by Fresenius Medical Care FMEG.DE in its top market, the United States, could rise by as much as 2% by the end of the year, its CEO said, as the impact of the pandemic on patients fades. WHY IT'S IMPORTANT Fresenius Medical Care is the world's largest kidney dialysis company, and the fallout from the pandemic - which led to an increase in deaths among patie

UPDATE 3-Fresenius marks restructuring end with Vamed exit, raises outlook Adds detail on Vamed exit in paragraphs 1-3, CEO quote in paragraph 4, analyst comment in paragraph 6 By Tristan Veyet May 8 (Reuters) - Germany's Fresenius FREG.DE said on Wednesday it had completed its restructuring with a "structured exit" from its loss-making service unit Vamed as it raised its outlook for 2024 after beating first-quarter forecasts.

German healthcare group Fresenius Q1 EBIT beats expectations May 7 (Reuters) - German healthcare group Fresenius FREG.DE first quarter results beat expectations, the company said on Wednesday, citing strong performance at its operating companies. First-quarter earnings before interests and taxes (EBIT) were 633 million euros ($679.78 million). That was above investors' expectation of 606 million euros, according to a consensus of forecasts from Vara research.

Fresenius Medical Care AG reports results for the quarter ended in March - Earnings Summary Fresenius Medical Care AG FMEG.DE reported quarterly adjusted earnings of 82 cents​​ per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of 52 cents. The mean expectation of nine analysts for the quarter was for earnings of 55 cents per share.

UPDATE 2-European shares close at record highs on financials boost Adds missing figure in para 4 Infineon jumps 12.9% on Q2 sales beat Zalando surges on Q1 operating profit beat French cognac companies up on China's attitude to trade dispute ECB can't be lenient with structural inflationary forces - Nagel Updated at 1629 GMT By Ankika Biswas and Johann M Cherian May 7 (Reuters) - European shares closed at record high levels on Tuesday, with financials stocks in the spotlight following upbeat ear

BUZZ-FMC slumps as unchanged FY guidance overshadows Q1 beat ** Shares in Fresenius Medical Care FMEG.DE fall more than 6% as reaffirmed guidance overshadows the German dialysis specialist's Q1 beat ** FMC confirms expecting revenue to grow by a low-to-mid-single digit percent rate y/y, with operating income growth of mid-to-high-teens percent rate